
So, when is the SoftBank Execution Fund III dropping?
Equity
00:00
ByteDance and the Healthcare Gamble
This chapter examines ByteDance's strategic acquisitions in the healthcare sector since 2020, focusing on the challenges posed by the U.S. market compared to China's. It also discusses the struggles and setbacks of direct-to-consumer companies in the alcohol space, as they navigate funding and partnership issues. Additionally, the chapter highlights SoftBank's significant financial losses and its implications for the broader investment landscape and startup ecosystem.
Transcript
Play full episode